Issue 42: 24 November 2020 |
|
|
|
Every week, HEADlines brings you the latest news, stories and commentaries in education and healthcare. This week, get insights on the latest developments in healthcare. |
|
COVID-19 mRNA vaccines - why is it such a big deal?
Moderna and Pfizer made headlines last week with both Phase 3 COVID-19 vaccine trials reporting efficacy of about 95%, bringing hope to the world that the pandemic has finally reached a turning point.
|
|
Healthcare in the Spotlight |
|
There are obstacles to a COVID-19 vaccine reaching the world’s poorest, including lack of funds, electricity and cold storage. |
|
|
|
Eight months after infection, most people who have recovered still have enough immune cells to fend off the COVID-19 virus and prevent illness. |
|
|
|
Protecting memory, maintaining blood vessel function and reducing neuro-inflammation are just some of ways that regular exercise benefits the brain. |
|
|
|
Early research suggests that poor gut health disrupts normal function of the brain-gut axis, contributing to the development of neurological disorders like dementia and Alzheimer's. |
|
|
|
A traditional Chinese medicine doctor believes the pancreas of Type 2 diabetics can be regenerated to make insulin, while another says evidence only shows that TCM can control diabetes. |
|
|
|
The WHO says there are health benefits for taking climate action in these five priority areas - adaptation & resilience, energy transitions, nature, clean transport, and finance. |
|
|
|
That's all for the week! |
|
Copyright © The HEAD Foundation Note: Credit to the rightful owners for photos and content used. Clicking the photos and embedded links will direct you to their source.
You're receiving this email because you have previously signed up for this newsletter and/or participated in The HEAD Foundation's events. |
|
|